Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock enjoyed a major increase of 10.5% on 1/24/25. The shares closed at $4.01. NORMAL trading volume accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 22.6% during the last week.
Current PriceTarget Research Rating
Perspective Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Perspective Therapeutics has a very low Appreciation Score of 3 and a very low Power Rating of 0, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment